Product Overview
The FOXO4-DRI 10mg premixed pen represents a significant breakthrough in senolytic peptide research. Specifically, scientists utilize this compound to disrupt the interaction between the FOXO4 protein and the p53 gene. This disruption triggers targeted apoptosis in aging, senescent cells. Consequently, researchers study FOXO4-DRI for its potential to reduce chronic inflammation and mitigate oxidative stress without damaging healthy tissue.
This 10mg premixed format provides a stable and ready-to-use solution for laboratory settings. Furthermore, the adjustable dosage dial ensures precise administration for controlled experiments. Therefore, this pen offers a reliable alternative to traditional peptide vials by maximizing dosing accuracy and structural stability.
Product Features and Specifications
We manufacture our FOXO4-DRI pens to meet the highest industry standards for purity and performance.
- Concentration: 10mg of high-purity senolytic peptide.
- Format: Premixed pen with a precision adjustable dosage dial.
- Stability: Optimized for long-term research integrity
- Efficiency: Streamlines administration while minimizing the risk of handling errors.
Primary Research Applications
In controlled laboratory environments, scientists utilize the FOXO4-DRI 10mg pen for diverse experimental models. Specifically, examples include:
- Senescence Pathway Modeling: Analyzing the lifecycle and impact of non-dividing cells.
- Protein Interaction Research: Studying the binding dynamics between FOXO4 and p53.
- Signaling Pathway Investigation: Mapping how apoptosis triggers impact surrounding tissue.
- Molecular Regulatory Analysis: Investigating the networks that govern cellular survival.
- In Vitro Experiments: Conducting controlled cellular regulation studies in a test-tube environment.
Mechanism of Action: Targeting "Zombie Cells"
FOXO4-DRI specifically targets and eliminates senescent cells, often called "zombie cells." These cells accumulate with age and release harmful inflammatory signals that accelerate tissue decline. Notably, the peptide works by interfering with the bond between FOXO4 and p53.
When FOXO4-DRI blocks this interaction, p53 leaves the cell nucleus and relocates to the mitochondria. This relocation triggers programmed cell death (apoptosis) exclusively in damaged cells. As a result, this targeted approach allows researchers to explore rejuvenation pathways while preserving the integrity of healthy cellular environments.
Research Potential and Vitality Studies
Current studies suggest that FOXO4-DRI possesses remarkable potential for restoring tissue health. Specifically, researchers have observed several benefits in experimental models:
- Organ Performance: Improving liver function and kidney filtering capacity by reducing the inflammatory burden.
- Systemic Vitality: Regenerating hair density and improving physical fitness in aged subjects.
- Health Span Extension: Investigating the reversal of age-related biomarkers and the restoration of youthful tissue characteristics.
Consequently, this peptide has gained significant attention in the fields of longevity and metabolic research development.
Reviews
There are no reviews yet.